For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240213:nRSM9769Ca&default-theme=true
RNS Number : 9769C Life Science REIT PLC 13 February 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BP5X4Q29
Issuer Name
LIFE SCIENCE REIT PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
Other
Comments
Hazelview Securities Inc. no longer having control or direction over a
client's assets.
3. Details of person subject to the notification obligation
Name
Hazelview Investments Inc.
City of registered office (if applicable)
Toronto
Country of registered office (if applicable)
Canada
4. Details of the shareholder
Name City of registered office Country of registered office
Hazelview Securities (US) LLC Toronto Canada
Hazelview Securities Inc. Toronto Canada
5. Date on which the threshold was crossed or reached
31-Jan-2024
6. Date on which Issuer notified
12-Feb-2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 1.080000 0.000000 1.080000 3784262
Position of previous notification (if applicable) 4.940000 0.000000 4.940000
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BP5X4Q29 3784262 0 1.080000 0.000000
Sub Total 8.A 3784262 1.080000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Hazelview Investments Inc. (Chain 2) Hazelview Securities (US) LLC (Subsidiary 2)
Hazelview Investments Inc. (Chain 1) Hazelview Securities Inc. (Subsidiary 1)
10. In case of proxy voting
Name of the proxy holder
Hazelview Securities Inc. and Hazelview Securities (US) LLC on behalf of its
client accounts.
The number and % of voting rights held
1.08
The date until which the voting rights will be held
Until the securities are sold.
11. Additional Information
12. Date of Completion
12-Feb-2024
13. Place Of Completion
Toronto, Ontario, Canada
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLGPUGGPUPCGUW